Columbia Care Inc. (CCHWF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Columbia Care Inc. (CCHWF) with AI Score 41/100 (Weak). Columbia Care Inc. is a cannabis company that cultivates, manufactures, and provides cannabis products and related services. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Columbia Care Inc. (CCHWF) Healthcare & Pipeline Overview
Columbia Care Inc. is a multi-state cannabis operator focusing on cultivation, manufacturing, and retail. With licenses in 18 jurisdictions, the company offers a range of cannabis products under various brands. It aims to establish a leading position in the evolving cannabis market through strategic expansion and operational efficiency.
Investment Thesis
Columbia Care Inc. presents an investment opportunity in the expanding cannabis market. The company's vertically integrated operations and multi-state presence provide a strong foundation for growth. Key value drivers include increasing revenue from its retail dispensaries and cultivation facilities. The company's focus on product innovation and brand development should drive customer loyalty and market share. However, investors should be aware of the risks associated with regulatory changes and market competition. With a market capitalization of $0.52 billion and a negative P/E ratio of -9.51, the company's profitability remains a concern. The company's high beta of 1.76 indicates higher volatility compared to the market. Successful execution of its expansion strategy and achievement of profitability are critical for long-term value creation.
Based on FMP financials and quantitative analysis
Key Highlights
- Columbia Care operates 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities as of June 15, 2022, showcasing its operational scale.
- The company holds licenses in 18 jurisdictions in the United States and the European Union, providing a broad geographic footprint.
- Columbia Care's product portfolio includes flowers, edibles, oils, and tablets, catering to diverse consumer preferences.
- The company's negative P/E ratio of -9.51 reflects current challenges in achieving profitability.
- Columbia Care's gross margin is 30.7%, indicating the profitability of its products after accounting for the cost of goods sold.
Competitors & Peers
Strengths
- Multi-state presence with licenses in key markets.
- Vertically integrated operations for better control and efficiency.
- Diverse product portfolio catering to different consumer segments.
- Established infrastructure of cultivation and retail facilities.
Weaknesses
- Negative profitability and high operating expenses.
- High beta indicating higher volatility compared to the market.
- Dependence on regulatory approvals and changes.
- Intense competition in the cannabis industry.
Catalysts
- Upcoming: Potential for new state cannabis legalization, expanding market opportunities.
- Ongoing: Increasing consumer acceptance of cannabis for medical and recreational use.
- Ongoing: Expansion of retail dispensary network in existing and new markets.
- Upcoming: Development and launch of new and innovative cannabis products.
- Ongoing: Strategic acquisitions and partnerships to expand market reach.
Risks
- Potential: Changing regulatory landscape and potential for stricter regulations.
- Ongoing: Intense competition from other cannabis companies.
- Potential: Fluctuations in cannabis prices and supply.
- Potential: Potential for negative public perception and stigma.
- Ongoing: Dependence on regulatory approvals and changes.
Growth Opportunities
- Expansion of Retail Footprint: Columbia Care has the opportunity to expand its retail dispensary network in existing and new markets. As more states legalize cannabis, the company can increase its revenue by opening new dispensaries and attracting more customers. The U.S. cannabis retail market is projected to reach $30 billion by 2025, providing a significant growth opportunity for Columbia Care. Strategic partnerships and acquisitions can accelerate this expansion.
- Product Innovation and Brand Development: The company can drive growth by developing new and innovative cannabis products that cater to evolving consumer preferences. Investing in research and development to create unique formulations and delivery methods can differentiate Columbia Care from its competitors. Building strong brand recognition and loyalty through effective marketing and branding strategies is also crucial. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly.
- Strategic Acquisitions and Partnerships: Columbia Care can pursue strategic acquisitions and partnerships to expand its market reach and enhance its product offerings. Acquiring smaller cannabis companies with complementary assets or technologies can provide access to new markets and customers. Partnering with established brands or retailers can also accelerate growth. These strategic moves can strengthen Columbia Care's competitive position and drive long-term value creation.
- International Expansion: With licenses in the European Union, Columbia Care has the opportunity to expand its operations internationally. The European cannabis market is growing rapidly, driven by increasing legalization and acceptance of medical cannabis. Columbia Care can leverage its expertise and resources to establish a presence in key European markets and capitalize on this growth opportunity. Navigating regulatory differences and cultural nuances will be critical for success.
- Focus on Medical Cannabis Market: Columbia Care can focus on the medical cannabis market by developing and marketing cannabis products specifically for medical patients. This includes conducting clinical trials to demonstrate the efficacy of its products for various medical conditions. Partnering with healthcare providers and research institutions can enhance the company's credibility and reach in the medical cannabis market. The medical cannabis market is expected to continue to grow as more research supports the therapeutic benefits of cannabis.
Opportunities
- Expansion into new markets as more states legalize cannabis.
- Development of new and innovative cannabis products.
- Strategic acquisitions and partnerships to expand market reach.
- Growth in the medical cannabis market.
Threats
- Changing regulatory landscape and potential for stricter regulations.
- Intense competition from other cannabis companies.
- Fluctuations in cannabis prices and supply.
- Potential for negative public perception and stigma.
Competitive Advantages
- Licenses: Holding licenses in multiple jurisdictions creates a barrier to entry.
- Vertically Integrated Operations: Controlling the supply chain from cultivation to retail enhances efficiency and quality control.
- Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
- Established Infrastructure: A network of cultivation and manufacturing facilities and dispensaries provides a competitive advantage.
About CCHWF
Founded in 2012 and headquartered in New York City, Columbia Care Inc. has grown into a significant player in the cannabis industry. The company cultivates, manufactures, and provides a diverse range of cannabis products, including flowers, edibles, oils, and tablets. These products are marketed under various brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. Columbia Care operates across 18 jurisdictions in the United States and the European Union, reflecting a broad geographic footprint. As of June 15, 2022, the company managed 131 facilities, comprising 99 dispensaries and 32 cultivation and manufacturing facilities, highlighting its vertically integrated business model. This integration allows Columbia Care to control its supply chain, ensuring product quality and consistency. The company's strategic focus includes expanding its retail footprint and enhancing its product offerings to meet the evolving demands of the cannabis market. Columbia Care aims to capitalize on the increasing legalization and acceptance of cannabis for both medical and recreational purposes.
What They Do
- Cultivates cannabis plants in controlled environments.
- Manufactures a variety of cannabis products, including flowers, edibles, oils, and tablets.
- Operates retail dispensaries to sell cannabis products directly to consumers.
- Provides cannabis products under various brands like Seed & Strain and Triple Seven.
- Holds licenses to operate in 18 jurisdictions in the United States and the European Union.
- Focuses on both medical and recreational cannabis markets.
- Manages a vertically integrated supply chain from cultivation to retail.
Business Model
- Cultivation and Manufacturing: Columbia Care cultivates cannabis and manufactures various products, controlling the supply chain.
- Retail Sales: The company generates revenue through direct sales to consumers at its dispensaries.
- Brand Licensing: Columbia Care licenses its brands to other operators in certain markets.
- Wholesale Distribution: The company distributes its products to other retailers and dispensaries.
Industry Context
Columbia Care operates in the rapidly growing cannabis industry, which is experiencing increasing legalization and acceptance across the United States and globally. The market is characterized by intense competition and evolving regulatory landscapes. Companies like AIHLF (Aleafia Health Inc.), CKDXF (Khiron Life Sciences Corp), CLAZF (Classiq Corp), IVEVF (iAnthus Capital Holdings, Inc.), and PEXXF (Planet 13 Holdings Inc.) are among the key players. The industry is driven by increasing consumer demand for both medical and recreational cannabis products. Columbia Care's vertically integrated model and multi-state presence position it to capitalize on these trends, but it must navigate regulatory hurdles and competitive pressures to succeed.
Key Customers
- Medical cannabis patients seeking relief from various medical conditions.
- Adult recreational cannabis users.
- Wholesale customers, including other dispensaries and retailers.
- Partners and licensees who use Columbia Care's brands and products.
Financials
Chart & Info
Columbia Care Inc. (CCHWF) stock price: Price data unavailable
Latest News
-
The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More
benzinga · Jan 21, 2022
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 2, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 1, 2019
-
Stocks That Hit 52-Week Lows On Monday
· Sep 30, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CCHWF.
Price Targets
Wall Street price target analysis for CCHWF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CCHWF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Monday
Leadership: Nicholas Keane Vita
CEO
Nicholas Keane Vita serves as the CEO of Columbia Care Inc., leading a workforce of 2505 employees. His background includes extensive experience in the cannabis industry, with a focus on strategic growth and operational efficiency. Vita has a proven track record of building and scaling cannabis businesses. He has been instrumental in expanding Columbia Care's footprint across multiple states and developing its vertically integrated business model. Vita's leadership is focused on driving innovation, enhancing customer experience, and creating long-term value for shareholders.
Track Record: Under Nicholas Keane Vita's leadership, Columbia Care has expanded its operations to 18 jurisdictions and established a strong presence in key cannabis markets. He has overseen the acquisition and integration of several cannabis companies, strengthening Columbia Care's competitive position. Vita has also focused on improving the company's financial performance and operational efficiency. Key milestones include the expansion of the retail dispensary network and the development of new and innovative cannabis products.
CCHWF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Columbia Care Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies on this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: The lack of comprehensive financial reporting increases the risk of investing in CCHWF.
- Lower Liquidity: The OTC market generally has lower trading volumes, leading to potential difficulties in buying or selling shares.
- Price Volatility: OTC stocks are often more volatile due to lower trading volumes and less regulatory oversight.
- Regulatory Risks: OTC-listed companies may face increased scrutiny and potential delisting if they fail to meet regulatory requirements.
- Information Asymmetry: Limited information availability can create an uneven playing field for investors.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Analyze the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Established Operations: Columbia Care has been operating since 2012 and has a network of cultivation and retail facilities.
- Multi-State Licenses: The company holds licenses in multiple jurisdictions, indicating regulatory compliance.
- Product Portfolio: A diverse portfolio of cannabis products suggests a well-developed business model.
- Employee Count: The company employs over 2500 people, suggesting a substantial operation.
What Investors Ask About Columbia Care Inc. (CCHWF)
What does Columbia Care Inc. do?
Columbia Care Inc. cultivates, manufactures, and retails cannabis products. The company operates across 18 jurisdictions in the United States and the European Union, with a focus on vertically integrated operations. Columbia Care offers a range of cannabis products, including flowers, edibles, oils, and tablets, under various brands. The company's business model involves cultivating cannabis, manufacturing products, and selling them directly to consumers through its retail dispensaries, as well as distributing to other retailers.
What do analysts say about CCHWF stock?
Analyst consensus on CCHWF stock is pending further AI analysis. Key valuation metrics, such as the negative P/E ratio of -9.51, indicate current challenges in achieving profitability. Growth considerations include the company's expansion strategy, product innovation, and market opportunities. Investors should monitor the company's financial performance, regulatory developments, and competitive landscape. The high beta of 1.76 suggests higher volatility compared to the market, which should be considered when evaluating the stock's risk profile.
What are the main risks for CCHWF?
The main risks for Columbia Care Inc. include regulatory uncertainty, intense competition, and financial challenges. Changes in cannabis regulations can significantly impact the company's operations and profitability. The cannabis industry is highly competitive, with numerous companies vying for market share. Columbia Care's negative profitability and high operating expenses pose financial risks. Other risks include fluctuations in cannabis prices and supply, as well as potential negative public perception and stigma. Investors should carefully consider these risks before investing in CCHWF.
What are the key factors to evaluate for CCHWF?
Columbia Care Inc. (CCHWF) currently holds an AI score of 41/100, indicating low score. Key strength: Multi-state presence with licenses in key markets.. Primary risk to monitor: Potential: Changing regulatory landscape and potential for stricter regulations.. This is not financial advice.
How frequently does CCHWF data refresh on this page?
CCHWF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CCHWF's recent stock price performance?
Recent price movement in Columbia Care Inc. (CCHWF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Multi-state presence with licenses in key markets.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CCHWF overvalued or undervalued right now?
Determining whether Columbia Care Inc. (CCHWF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CCHWF?
Before investing in Columbia Care Inc. (CCHWF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information.
- The cannabis industry is subject to rapid changes and regulatory uncertainty.